Xiaotong Lu
Impact in
-
- Cancer, Hypoxia, and Metabolism
- Pharmacology top 10%
- Drug-Induced Hepatotoxicity and Protection
Papers in
-
- Ubiquitin and proteasome pathways 2
- Cell death mechanisms and regulation 2
- Circular RNAs in diseases 2
- Co-authors
- Guo‐Ping Shi (1 shared paper)Junyan Xu (1 shared paper)Shutao Yin (4 shared papers)Hongbo Hu (3 shared papers)You Yin (4 shared papers)Lihong Fan (3 shared papers)Enxiang Zhang (3 shared papers)Yizhi Jane Tao (3 shared papers)
- Journals
- Frontiers in Immunology (3 papers)Journal of Inorganic Biochemistry (2 papers)Bioactive Materials (1 paper)Journal of Plant Physiology (1 paper)Acta Pharmaceutica Sinica B (1 paper)
- Partner nations
- ChinaUnited StatesSaint Kitts and Nevis
In The Last Decade
Xiaotong Lu
41 papers receiving 811 citations
Xiaotong Lu's Hit Papers
Peers
Comparison fields: 5 of 99
- Cancer Research 97
- Pharmacology 43
- Immunology 100
- Molecular Biology 239
- Oncology 80
Countries citing papers authored by Xiaotong Lu
This map shows the geographic impact of Xiaotong Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaotong Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaotong Lu more than expected).
Fields of papers citing papers by Xiaotong Lu
This network shows the impact of papers produced by Xiaotong Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaotong Lu. The network helps show where Xiaotong Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaotong Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | ACSS2 acts as a lactyl-CoA synthetase and couples KAT2A to function as a lactyltransferase for histone lactylation and tumor immune evasion Hit paper breakdown → | 2024 | 137 |
| 2 | 2015 | 108 | |
| 3 | 2018 | 50 | |
| 4 | 2014 | 48 | |
| 5 | 2017 | 44 | |
| 6 | 2019 | 36 | |
| 7 | 2013 | 35 | |
| 8 | 2019 | 32 | |
| 9 | 2017 | 30 | |
| 10 | 2022 | 27 | |
| 11 | 2021 | 27 | |
| 12 | 2021 | 23 | |
| 13 | 2017 | 19 | |
| 14 | 2009 | 19 | |
| 15 | 2015 | 16 | |
| 16 | 2018 | 15 | |
| 17 | 2015 | 14 | |
| 18 | 2016 | 13 | |
| 19 | 2020 | 12 | |
| 20 | 2018 | 12 |
About Xiaotong Lu
Xiaotong Lu is a scholar working on Molecular Biology, Immunology, Oncology, Surgery and Epidemiology, having authored 45 papers that have together received 819 indexed citations. Recurring topics across this work include Biochemical effects in animals (3 papers), Ubiquitin and proteasome pathways (2 papers), Metal-Organic Frameworks: Synthesis and Applications (2 papers), Cell death mechanisms and regulation (2 papers), Circular RNAs in diseases (2 papers), Neurological Disease Mechanisms and Treatments (2 papers), Neurological Disorders and Treatments (2 papers) and Metal complexes synthesis and properties (2 papers). The work is most often cited by research in Cancer Research (97 citations), Pharmacology (43 citations), Immunology (100 citations), Molecular Biology (239 citations) and Oncology (80 citations). Xiaotong Lu has collaborated with scholars based in China, United States and Saint Kitts and Nevis. Frequent co-authors include Guo‐Ping Shi, Junyan Xu, Shutao Yin, Hongbo Hu, You Yin, Lihong Fan, Enxiang Zhang, Yizhi Jane Tao, Ming Yuan and Shudi Luo. Their work appears in journals such as Frontiers in Immunology, Journal of Inorganic Biochemistry, Bioactive Materials, Journal of Plant Physiology and Acta Pharmaceutica Sinica B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.